KAIST ์ฐ๊ตฌํ์ด MIT, ๋ง์ดํฌ๋ก์ํํธ์ ๊ณต๋์ผ๋ก '์ ์ํ ์ ๋๋ต' ๊ธฐ์ ์ ๊ฐ๋ฐํ๋ค. ์ด ๊ธฐ์ ์ GPU ๋ฉ๋ชจ๋ฆฌ ์ฌ์ฉ๋์ ์ต๋ 16๋ฐฐ ์ค์ด๋ฉด์๋ ์์ถ๋ ์๊ฐ ์ ๋ณด๋ฅผ ๊ณ ํด์๋๋ก ๋ณต์ํ์ฌ AI์ ์ฑ๋ฅ์ ํฅ์์ํจ๋ค.
KAIST, KIMM, ๊ณ ๋ ค๋ ์ฐ๊ตฌํ์ด ๋ฌผ ์์ ๋ฌ ๊ธ์ ๋ฐ๋ง์ ๋ค์ํ 3์ฐจ์ ํ๋ฉด์ ์ฎ๊ธฐ๋ '์๋ฉด ๋ถ์ ๋๋ ธ์ ์ฌ ์ธ์' ๊ธฐ์ ์ ๊ฐ๋ฐํ๋ค. ์ด ๊ธฐ์ ์ ์ด, ์๋ ฅ, ์ ์ฐฉ์ ์์ด ๋๋ ธ ํจํด์ ์ ์งํ๋ฉฐ ์ฐ์์ด๋ ๊ณก๋ฉด ๋ฑ ๋ฏผ๊ฐํ ํ๋ฉด์๋ ์ ์ฉ ๊ฐ๋ฅํด ์ค๋งํธ ๋์ , ์จ์ด๋ฌ๋ธ ๊ธฐ๊ธฐ ๋ฑ ํ์ฉ์ด ๊ธฐ๋๋๋ค.
KAIST research shows enhanced regulations on dual-use research, which can pose security threats, may hinder essential scientific advancements. Analysis of 600,000 US patent studies revealed that regulated research often has higher scientific impact, suggesting a need for international cooperation over unilateral restrictions.
KAIST Professor Son Hun has been selected as the June recipient of the Korea Science and Technology Award for developing a low-cost, high-precision displacement sensor for real-time disaster monitoring of small and medium-sized infrastructure.
The Ministry of SMEs and Startups held an event for 12 'Chogakcha' startups in non-metropolitan areas, nurturing 804 companies to date. The proportion of new companies selected from these regions increased to 35.5% this year.
KAIST and Korea University researchers found that 13-HODE, a natural lipid metabolite, directly inhibits mTOR, a key regulator of cancer cell growth. This discovery opens avenues for new anti-cancer therapies targeting lipid metabolism.
KAIST ์ฐ๊ตฌํ์ด ์์ ์ ์ํฉ์ ์ดํดํด ํ์ค๊ฐ ์๋ ์๋ฆฌ๋ฅผ ์์ฑํ๋ AI ๊ธฐ์ 'ํ๋ฐ์ค'(PAVAS)๋ฅผ ๊ฐ๋ฐํ๋ค. ์ด ๊ธฐ์ ์ ๋ฌผ์ฒด์ ๋ฌผ๋ฆฌ ์ ๋ณด๋ฅผ ์ถ๋ก ํด ์ํฅ ์ ์์ ์๋ํํ๊ณ AR/VR, ๋ฉํ๋ฒ์ค ๋ฑ ๋ค์ํ ๋ถ์ผ์ ํ์ฉ๋ ์ ๋ง์ด๋ค.
Researchers at KAIST in South Korea have discovered how graphene oxide selectively attacks harmful bacteria while leaving human cells largely unaffected. The material binds to phosphatidylglycerol (POPG), a lipid found in bacterial membranes but not in human cells, causing bacterial membranes to destabilise and break apart. This mechanism helps explain the antibacterial effect of graphene-based products, including toothbrushes that have already sold over 10 million units, though researchers caution that real-world effectiveness varies and most evidence comes from laboratory and animal studies rather than human clinical trials.
